Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 8,600 shares, a growth of 109.8% from the December 31st total of 4,100 shares. Based on an average trading volume of 27,900 shares, the days-to-cover ratio is currently 0.3 days.

Bavarian Nordic A/S Stock Performance

BVNRY stock traded down $0.21 during midday trading on Friday, reaching $9.07. The company's stock had a trading volume of 7,866 shares, compared to its average volume of 7,576. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 13.15 and a beta of 1.65. Bavarian Nordic A/S has a 1 year low of $6.86 and a 1 year high of $14.60. The stock has a fifty day simple moving average of $9.01 and a two-hundred day simple moving average of $10.13.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.